中文|한국어|日本語
News Hotline:0531-85876663
点击这里给我发消息

Sino-South Korean biological medicine projects enters Qingdao High-tech Zone

2019/8/8 16:41:09   source:sdchina.com

The signing ceremony of Sino-South Korean biological medicine projects was held in Qingdao High-tech Zone on August 6, 2019. Feng Wei, inspector of Industry and Information Bureau of Qingdao High-tech Zone, Yin Yilin, executive vice director of leading group of macroeconomic operation of Qingdao High-tech Zone, An Guangzhu, consul of Consulate-general of South Korea to Qingdao, and Kang Zhenhan, president of South Korea Vaccine Association attended the signing ceremony.

The contracted projects include degradable medical apparatus and instruments project invested by South Korean U&I and CRO project jointly invested by Beijing Chuangli Kechuang Company and South Korean CLIPS. The degradable and implantable medical apparatus represents the first-class standard of this kind of products and will further promote the development of high-end medical apparatus industry in Qingdao High-tech Zone. The CRO project will provide one-stop service for medical enterprises in and near Qingdao City in fields of new drug research, clinical test and post-marketing research on technological upgrading. It will be the first international biological medicine research CRO company in Shandong Province.

The signing marks a breakthrough in the cooperation between Qingdao High-tech Zone and South Korea in the biomedical industry and will promote the agglomeration of more high-quality resources in Qingdao High-tech Zone.

Founded in 1993, U&I has been committed to the research and production of high-tech products of degradable new materials and pain management nursing. The company went public on KSDAQ in 2015. Now it operates in nearly 30 countries and its products enjoy a good reputation in the global market.

CLIPS is a customer-based clinical trail CRO company that offers the best and all-around comprehensive solutions. It aims to develop into the only global top biological drug development in South Korea.

Beijing Chuanli Kechuang Medical Technology Company is a high-tech enterprises as well as an influential scientific and technological CRO company.

Related Stories

Photos

Sponsor:Information Office of Shandong Provincial People’s Government